十年一药,谁在豪赌?文|张钰铮编辑|方婷封面来源|电影《我不是药神》截图“双靶点”减重药的问世,在全球医药市场掀起了巨浪。然而这场科技与商业的盛宴中,中外药企尝到的滋味却截然不同。由全球市值第一的制药公司“礼来”研发的减肥神药“替尔泊肽”,去年卖了164亿美金。能卖这么多,是因为它能同时模仿两种天然激素,GLP-1和GIP双靶点,GLP-1抑制食欲、GIP控制血糖,双管齐下,效果翻倍。而来自中国...
Source Link十年一药,谁在豪赌?文|张钰铮编辑|方婷封面来源|电影《我不是药神》截图“双靶点”减重药的问世,在全球医药市场掀起了巨浪。然而这场科技与商业的盛宴中,中外药企尝到的滋味却截然不同。由全球市值第一的制药公司“礼来”研发的减肥神药“替尔泊肽”,去年卖了164亿美金。能卖这么多,是因为它能同时模仿两种天然激素,GLP-1和GIP双靶点,GLP-1抑制食欲、GIP控制血糖,双管齐下,效果翻倍。而来自中国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.